When making a decision about the approval of a new product NICE (National Institute for Health and C...
Read moreThe Head of Agency Group (HAG) is a recently launched network created by the European Health Technol...
Read moreThe use of combination therapy is increasingly becoming the standard of care in oncology as cancers ...
Read moreThe IHSI is an independent legal entity, with representatives from eight member countries.
Read moreIn oncology, a hazard ratio (HR) is commonly used to estimate the treatment effect for survival endp...
Read moreThe QALY Shortfall aims to capture and recognise disease severity by assessing the degree of quality...
Read moreAn overview of the product life cycle. The product life cycle must be managed efficiently to generat...
Read moreInsights from pharmaceuticals, market access and Team Remap Q3 2021.
Read moreWe outline the 3 key components of a good value proposition, designed to demonstrate the value of ne...
Read moreInnovative therapies for rare diseases may only be available in a select number of countries in Euro...
Read more